A role of the use of fluoroquinolones in the development of resistance to ciprofloxacin in Streptococcus pneumoniae in Canada has been recently suggested (2). We would like to contribute support for this hypothesis from three different perspectives.
No takes yet. Share an insight, caveat, or question.
Garcı́a-Rey et al. (2000) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: